TLV Medical Center
Tel Aviv, Israel
NCT Number: NCT04241198
The study will include up to 30 AMD patients, recruited by two medical centers, Tel-Aviv medical center and Assuta Hashalom medical center. At the screening visit, the patients will be imaged in their tested, eligible eye(s), using a commercial Zeiss Cirrus or Heidelberg Spectralis OCT.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Tel Aviv, Israel
Screening visit:
For patients eligible to participate in the study, the following procedure will be done in the "screening visit" at the clinic:
OCT scanning pattern:
Setup and tutorial home visit:
The device will be delivered to the patient's home with a setup guide attached to the package. The patient will read the setup guide instructions, unpack the device, place it on a table and connect it to a power supply. Upon first usage a tutorial clip, explaining how to operate the device and self-image the eyes, will be automatically displayed on the device's external screen. Following the tutorial patients will be instructed to scan their study eye(s). A remote support service, provided by the sponsor, will be available as needed. Its phone number will be given to the patient and will be attached to the device's base.
Daily home testing:
For each eligible eye, the following procedure will be done in the "Daily testing" at the patients' homes:
Exit visit:
For each eligible eye, the following procedure will be done in the "Exit visit" at the clinic:
OCT scanning pattern:
6.Patient's experience questionnaire
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NA
Time frame: 30 days
To describe the dynamics of retinal fluid in eyes undergoing anti-VEGF therapy as manifested in self-operated OCT in daily home testing
Time frame: 30 days
by a patient experience questionnaire.
Time frame: 30 days
E. To evaluate the level of agreement between OCT images captured by Notal-OCT V3.0 and a commercial OCT, for the presence of fluid, in the central 10 degrees of the macula, at screening and exit visits.
Notal Vision Ltd.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.